Bristol Myers (BMY) director Derica Rice granted 672 deferred share units

Rhea-AI Filing Summary

Bristol Myers Squibb director Derica W. Rice received a grant of deferred share units as part of non-employee director compensation. On this Form 4, Rice was awarded 672.5100 Deferred Share Units at a reference price of $57.6200 per unit, increasing her direct holdings of these units to 41,068.6810. Each unit is designed to convert into one share of common stock upon settlement, which occurs when she ceases to be a director or at a future date she previously selected. The position also reflects deferred compensation and dividends reinvested under the company’s 1987 Deferred Compensation Plan for Non-Employee Directors, making this a routine, compensation-related equity accrual rather than an open-market trade.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Rice Derica W

Role null

Type	Security	Shares	Price	Value
Grant/Award	Deferred Share Units	672.51	$57.62	$39K

Holdings After Transaction: Deferred Share Units — 41,068.681 shares (Direct, null)

Footnotes (1)

1. Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Key Figures

Deferred share units granted: 672.5100 units Reference price per unit: $57.6200 per unit Total deferred share units held: 41,068.6810 units +2 more

5 metrics

Deferred share units granted 672.5100 units Grant to Derica W. Rice on 2026-06-30

Reference price per unit $57.6200 per unit Price associated with the 672.5100 Deferred Share Units

Total deferred share units held 41,068.6810 units Direct holdings after the reported transaction

Underlying common stock 672.5100 shares Each Deferred Share Unit linked to one share of common stock

Conversion or exercise price $0.0000 Deferred Share Units convert into common stock at no exercise price

Key Terms

Deferred Share Units, 1987 Deferred Compensation Plan for Non-Employee Directors, dividends reinvested

3 terms

Deferred Share Units financial

"Each Deferred Share Unit will be converted into a share of common stock upon settlement."

Deferred share units are promises that give an executive or director the right to receive company shares or their cash value at a future date, often when they retire or leave the company. Think of them as a paycheck held in a savings account that converts into stock later; they matter to investors because they tie pay to long-term performance, create potential future dilution of shares, and represent a delayed cash or share obligation the company must eventually fulfill.

1987 Deferred Compensation Plan for Non-Employee Directors financial

"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."

dividends reinvested financial

"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:18 PM Accepted by SEC EDGAR 07/02/2026 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rice Derica W

(Last) (First) (Middle)

BRISTOL-MYERS SQUIBB COMPANY

ROUTE 206 AND PROVINCE LINE ROAD

(Street)

PRINCETON NEW JERSEY 08543

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BRISTOL MYERS SQUIBB CO [ BMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	06/30/2026		A		672.51		(1)	(1)	Common Stock, $0.10 par value	672.51	$57.62	41,068.681(2)	D

Explanation of Responses:

1. Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

2. Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Remarks:

	/s/ Amy Fallone, attorney-in-fact for Derica W. Rice	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Bristol Myers (BMY) report for Derica W. Rice?

Bristol Myers reported that director Derica W. Rice received 672.5100 Deferred Share Units. These units are part of her non-employee director compensation and are tied to the company’s common stock, rather than an open-market purchase or sale.

How many deferred share units does Derica W. Rice hold in BMY after this Form 4?

After this grant, Derica W. Rice directly holds 41,068.6810 Deferred Share Units. This total includes the newly awarded units plus prior deferred compensation and dividends that were reinvested under the company’s 1987 Deferred Compensation Plan for Non-Employee Directors.

When will Derica W. Rice’s Bristol Myers deferred share units convert into common stock?

Each Deferred Share Unit will convert into one share of Bristol Myers common stock upon settlement. Settlement occurs when Rice ceases to be a director or on a future date she previously specified, providing long-term, deferred equity exposure.

Is Derica W. Rice’s Bristol Myers Form 4 a market buy or sell of BMY stock?

The Form 4 shows a grant of deferred share units to Derica W. Rice, not a market buy or sell. It is classified as a grant or award acquisition, reflecting non-employee director compensation rather than active trading in Bristol Myers stock.

What price is associated with Derica W. Rice’s new Bristol Myers deferred share units?

The new grant of 672.5100 Deferred Share Units is reported at $57.6200 per unit. While this price is disclosed in the Form 4, the units themselves are deferred equity instruments linked to Bristol Myers common stock rather than immediate cash transactions.